{
    "clinical_study": {
        "@rank": "82248", 
        "acronym": "GLP-1-CPOP", 
        "arm_group": [
            {
                "arm_group_label": "Type 1 Diabetes", 
                "description": "patients with long standing T1D"
            }, 
            {
                "arm_group_label": "Healthy volunteer", 
                "description": "healthy volunteers with normal glucose tolerance"
            }
        ], 
        "biospec_descr": {
            "textblock": "blood samples"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine whether there are differences in pancreatic uptake\n      of the radiotracer between healthy individuals and patients with type 1 diabetes. If T1D\n      patients have a markedly reduced uptake, the compound may be suitable for estimation of\n      pancreatic beta cell mass, i.e. the cells in the pancreas that produce insulin."
        }, 
        "brief_title": "GLP-1 Receptor Targeting in Diabetic and Healthy Individuals", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  type 1 Diabetes\n\n        Exclusion Criteria:\n\n          -  breast feeding\n\n          -  pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "21 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Type 1 Diabetes patients and healthy volunteers responding to advertisment"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01825148", 
            "org_study_id": "RUNMC-EX-BCM-2012", 
            "secondary_id": "2012-000619-10"
        }, 
        "intervention": {
            "arm_group_label": [
                "Type 1 Diabetes", 
                "Healthy volunteer"
            ], 
            "intervention_name": "radiolabeled Exendin", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Pentetic Acid", 
                "Edetic Acid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Diabetes", 
        "lastchanged_date": "April 2, 2013", 
        "location": {
            "contact": {
                "email": "m.gotthardt@nucmed.umcn.nl", 
                "last_name": "Martin Gotthardt, MD, PhD", 
                "phone": "+31 24 36", 
                "phone_ext": "14048"
            }, 
            "facility": {
                "address": {
                    "city": "Nijmegen", 
                    "country": "Netherlands", 
                    "state": "Gelderland", 
                    "zip": "6500 HB"
                }, 
                "name": "Radboud University Nijmegen Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_groups": "2", 
        "official_title": "Clinical Proof-of-principle of the Determination of the Beta Cell Mass in Vivo by SPECT Imaging With the 111-In-labeled GLP-1 Analogue DTPA(Diethylenetriamine Pentaacetic Acid)-[K40]-Exendin 4", 
        "overall_contact": {
            "email": "m.gotthardt@nucmed.umcn.nl", 
            "last_name": "Martin Gotthardt, MD, PhD", 
            "phone": "+31 24 36", 
            "phone_ext": "14048"
        }, 
        "overall_contact_backup": {
            "email": "w.vanderweg@nucmed.umcn.nl", 
            "last_name": "Wietske van der Weg, MSc", 
            "phone": "+31 24 36", 
            "phone_ext": "14048"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "uptake will be given as counts per MBq injected activity as determined by calibrated SPECT/CT scanner with attenuation correction.", 
            "measure": "pancreatic uptake of radiolabeled Exendin", 
            "safety_issue": "No", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01825148"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Radboud University", 
            "investigator_full_name": "Martin Gotthardt", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Radboud University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Radboud University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}